Table 2

Characteristics of all Ajmaline positive tested individuals divided by pathogenic SCN5A mutation.

Pathogenic SCN5A mutationNo SCN5A mutation
9 Families71 Families
SCD families with youngest case >45 years (%)0 (0, 0–30)28 (39, 29–51)*
Families with >1 SCD case (%)1 (11, 2–44)48 (68, 56–77)*
Families with PAS1 (11, 2–44)35 (49, 38–61)*
9 Individuals103 Individuals
HR <60 bpm before Ajmaline, n (%)3 (33, 12–65)33 (32, 24–42)
HR <60 bpm after Ajmaline, n, (%)0 (0, 0–29)10 (10, 5–17)
PQ >200 ms after Ajmaline, n (%)1 (11, 2–44)24 (23, 16–32)
QRS >120 ms after Ajmaline, n (%)1 (11, 2–44)12 (12, 7–19)
  • Variables are expressed as N (%—95% CI for proportion).

  • *P<0.05.

  • HR, heart rate; PAS, premature atherosclerosis; SCD, sudden cardiac death.